Published online before print September 24, 2009

This Article Full Text (Rapid PDF) All Versions of this Article: jmoldx.2009.090059v1 11/6/514    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Vermeer, S. Articles by Scheffer, H. PubMed PubMed Citation Articles by Vermeer, S. Articles by Scheffer, H.

Copyright © 2009 American Society for Investigative Pathology
Journal of Molecular Diagnostics, doi:10.2353/jmoldx.2009.090059

Accepted for publication June 16, 2009.

Technical Advance

Design and Validation of a Conformation Sensitive Capillary Electrophoresis-Based Mutation Scanning System and Automated Data Analysis of the More than 15 kbp-Spanning Coding Sequence of the SACS Gene

Sascha Vermeer^*, Rowdy P.P. Meijer^*, Tom G.J. Hofste^*, Daniëlle Bodmer^*, Ermanno A.J. Bosgoed^*, Frans P.M. Cremers^*, Berry H.P. Kremer, Nine V.A.M. Knoers^*, and Hans Scheffer^*@

From the Departments of Human Genetics,* Neurology, and the Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

^@ To whom correspondence should be addressed. E-mail: H.Scheffer{at}antrg.umcn.nl.

	Abstract

In this study, we developed and analytically validated a fully automated, robust confirmation sensitive capillary electrophoresis (CSCE) method to perform mutation scanning of the large SACS gene. This method facilitates a rapid and cost-effective molecular diagnosis of autosomal recessive spastic ataxia of Charlevoix-Saguenay. Critical issues addressed during the development of the CSCE system included the position of a DNA variant relative to the primers and the CG-content of the amplicons. The validation was performed in two phases; a retrospective analysis of 32 samples containing 41 different known DNA variants and a prospective analysis of 20 samples of patients clinically suspected of having autosomal recessive spastic ataxia of Charlevoix-Saguenay. These 20 samples appeared to contain 73 DNA variants. In total, in 32 out of the 45 amplicons, a DNA variant was present, which allowed verification of the detection capacity during the validation process. After optimization of the original design, the overall analytical sensitivity of CSCE for the SACS gene was 100%, and the analytical specificity of CSCE was 99.8%. In conclusion, CSCE is a robust technique with a high analytical sensitivity and specificity, and it can readily be used for mutation scanning of the large SACS gene. Furthermore this technique is less time-consuming and less expensive, as compared with standard automated sequencing.